uniQure N.V. business relationships
Companies named in uniQure N.V.’s 10-K filed 2026-03-02, and public companies whose annual reports name uniQure N.V.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 6.1 / 10
- AI naming
- 100 / 100 Top 1% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in uniQure N.V.’s annual report 2
“In June 2020, we entered into a commercialization and license agreement with CSL Behring LLC (the "CSL Behring Agreement") pursuant to which CSL Behring LLC ("CSL Behring") received exclusive global rights to HEMGENIX.” SEC filing
“The use of AAV9 to deliver any sequence that affects the expression of the GRIK2 gene in humans has been exclusively licensed from Regenxbio Inc. ("Regenxbio").” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.